Lite Strategy, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
LITS Nasdaq 2836 www.litestrategy.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Lite Strategy, Inc.

Sellas’ Experimental Drug SLS009 Appears To Be Leading The CDK9 Race, Says Alliance Global – Analyst Sees About 200% Upside Potential - Aug 12th, 2026 10:07 am
Can LitVM Bring Smart Contracts to Litecoin Without Changing Its Identity? - Jun 23rd, 2026 2:15 am
Exclusive: Lite Strategy leads $1m investment in Litecoin Layer 2 platform LitVM - Jun 18th, 2026 5:45 am
Is Lite Strategy (NASDAQ:LITS) In A Good Position To Invest In Growth? - Apr 25th, 2026 6:42 am